
This two-drug combo can shrink breast cancer tumors
Credit: CC0 Public Domain In a new study from McGill University, researchers discovered a new targeted combination drug therapy that efficiently reduces tumor growth in metastatic breast cancer. Their findings could lead to the development of a new first-line targeted therapy for the treatment of triple-negative breast cancer (TNBC), with
606 Views